@mvaduganathan @JavedButler1 @lamcardio @AndrewJSauer @SJGreene_md @gcfmd @DrMarthaGulati @hvanspall @dranulala @BiykemB @hfcollaboratory @HFA_President @HFSA @GMCRosano jamanetwork.com/journals/jama/ Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction In patients with cardiometabolic HFpEF, semaglutide and tirzepatide showed more than 40% risk reduction for the composite of hospitalization for heart failure or all-cause mortality compared with a placebo proxy
However, theyre meant to be used as part of a long-term protocol along with lifestyle changes under a doctors supervision
J Thromb Thrombolysis 41(1):187205 Shikdar S, Vashisht R, Zubair M, Bhattacharya PT International Normalized Ratio: Assessment, Monitoring, and Clinical Implications
Ver tambin:
Schedule a consultation today, and lets create a plan tailored to your weight loss goals
10, 2022 from Kim, H., Park, H., & Lee, S